Fig. 2From: Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarkerMean serum amyloid A (SAA) (a) and C-reactive protein (CRP) (b) by treatment modality and study visit. MTX methotrexate, ETN etanercept, DMARD disease-modifying anti-rheumatic drug. Error bar denotes standard deviationBack to article page